Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Dec. 27, 2019	Dec. 28, 2018
Income Statement [Abstract]
Revenue	$ 4,253,597	$ 4,265,349
Costs and Expenses:
Cost of services provided	3,768,113	3,794,445
Depreciation and amortization	147,936	150,721
Selling and general corporate expenses	83,255	104,130
Gain on sale of Healthcare Technologies	0	(157,309)
Costs and Expenses	3,999,304	3,891,987
Operating income	254,293	373,362
Interest and Other Financing Costs, net	79,585	82,978
Income Before Income Taxes	174,708	290,384
Provision for Income Taxes	28,825	39,708
Net income	145,883	250,676
Less: Net income (loss) attributable to noncontrolling interest	122	(6)
Net income attributable to Aramark stockholders	$ 145,761	$ 250,682
Earnings per share attributable to Aramark stockholders:
Basic (in dollars per share)	$ 0.59	$ 1.02
Diluted (in dollars per share)	$ 0.57	$ 0.99
Weighted Average Shares Outstanding:
Basic (in shares)	248,731	246,887
Diluted (in shares)	254,121	253,656